| Literature DB >> 2491140 |
A Georgotas1, R E McCue, B Reisberg, S H Ferris, N Nagachandran, I Chang, P Mir.
Abstract
Seventy-eight nondemented elderly depressed patients underwent an extensive battery of cognitive tests both before and after seven weeks of treatment with nortriptyline, phenelzine, or placebo. Clinical and cognitive evaluations of the patients were under double-blind conditions. Response to treatment did not appear to significantly affect cognitive capacity; neither did treatment with an active substance as compared to placebo. In addition, the baseline level of cognitive functioning did not appear related to whether a patient responded to treatment. The authors conclude that under optimal conditions neither antidepressant produces measurable changes in the cognitive capacity of nondemented elderly patients.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2491140 DOI: 10.1017/s1041610289000141
Source DB: PubMed Journal: Int Psychogeriatr ISSN: 1041-6102 Impact factor: 3.878